Significance of serum levels of angiopoietin-2 and its relationship to Doppler ultrasonographic findings in rheumatoid arthritis patients

Egyptian Rheumatologist

Volumn 36, Issue 1, 2014, Pages 15-20

  Soliman, Samar G ^a   Korah, Tarek E ^a   Hammoda, Ghada E ^a   Mousa, Waleed ^a  

^a MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Angiopoietin 2; Doppler ultrasonography; Rheumatoid arthritis

Indexed keywords

ANGIOPOIETIN 2; C REACTIVE PROTEIN; RHEUMATOID FACTOR;

ADULT; ARTICLE; BLOOD CELL COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DAS28; DOPPLER FLOWMETRY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; MIDDLE AGED; MORNING STIFFNESS; PAIN ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SCORING SYSTEM; SYNOVIUM; THICKNESS; TOTAL SIGNAL SCORE; VISUAL ANALOG SCALE; ANALYTICAL PARAMETERS; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; JOINT RADIOGRAPHY; LABORATORY TEST; MUSCULOSKELETAL SYSTEM PARAMETERS; NEOVASCULARIZATION (PATHOLOGY); PATHOGENESIS; PROTEIN ANALYSIS; SYNOVIAL THICKNESS; ULTRASOUND SCANNER;

EID: 84891065991     PISSN: 11101164     EISSN: 20902433     Source Type: Journal    
DOI: 10.1016/j.ejr.2013.09.001     Document Type: Article

References (42)

1. Paleolog E.M., Fava R.A. Angiogenesis in rheumatoid arthritis: implications for future therapeutic strategies. Springer Semin Immunopathol 1998, 20:73-94.
2. Walsh D.A. Angiogenesis and arthritis. Rheumatology 1999, 38:103-112.
3. Szekanecz Z., Koch A.E. Mechanism of disease: angiogenesis in inflammatory diseases. Nat Clin Pract Rheumatol 2007, 3:635-643.
4. Veale D.J., Fearon U. Inhibition of angiogenic pathways in rheumatoid arthritis: potential for therapeutic targeting. Best Pract Res Clin Rheumatol 2006, 20:941-947.
5. Koch A.P. Angiogenesis as a target in rheumatoid arthritis. Ann Rheum Dis 2003, 62(Suppl. 2):ii60-ii67.
6. Fagiani E., Lorentz P., Kopfstein L., Christofori G. Angiopoietin-1 and angiopoietin-2 exert antagonistic functions in tumor angiogenesis. Yet both induce Lymphangiogenesis. Cancer Res 2011, 71:5717-5727.
7. Rasul S., Reiter M.H., Ilhan A., Lampichler K., Wagner L., Kautzky-Willer A. Circulating angiopoietin-2 and soluble Tie-2 in type 2 diabetes mellitus: a cross sectional study. Cardiovasc Diabetol 2011, 10:55.
8. Clavel G., Boissier M.C. Angiogenesis markers in rheumatoid arthritis. Future Rheumatol 2008, 3(2):153-159.
9. Vreju F.L., Ciurea M., Rosu A., Musetescu A., Grecu D., Ciurea P. Power Doppler sonography, a non-invasive method of assessment of the synovial inflammation in patients with early rheumatoid arthritis. Rom J Morphol Embryol (Romania) 2011, 52(2):637-643.
10. Khong T.L., Larsen H., Raatz Y., Paleolog E. Angiogenesis as a therapeutic target in arthritis: learning the lessons of the colorectal cancer experience. Angiogenesis 2007, 10(4):243-258.
11. Carotti M., Salaffi F., Morbiducci J., Ciapetti A., Bartolucci L., Gasparini S., et al. Colour Doppler ultrasonography evaluation of vascularization in the wrist and finger joints in rheumatoid arthritis patients and healthy subjects. Eur J Radiol (Ireland) 2012, 81(8):1834-1838.
12. Taylor P.C., Steuer A., Gruber J., Cosgrove D.O., Blomley M.J.K., Marsters P.A., et al. Comparison of ultrasonographic assessment of synovitis and joint vascularity with radiographic evaluation in a randomized, placebo-controlled study of infliximab therapy in early rheumatoid arthritis. Arthritis Rheumatism 2004, 50(4):1107-1116.
13. Szkudlarek M., Narvestad E., Klarlund M., Court-Payen M., Thomsen H.S., Ostergaard M. Ultrasonography of the metatarsophalangeal joints in rheumatoid arthritis: comparison with magnetic resonance imaging, conventional radiography, and clinical examination. Arthritis Rheum 2004, 50(7):2103-2112.
14. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988, 31(3):315-324.
15. Prevoo M.L., VAN 'T HOF M.A., Kuper H.H., van Leeuwen M.A., van de Putte L.B., van Riel P.L. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995, 38(1):44-48.
16. Laurell C.B. Electroimmunoassay. Scand J Clin Lab Invest 1972, 29(Suppl. 124):21-37.
17. Wolfe F., Cathey M.A., Roberts F.K. The latex test revisited. Rheumatoid factor testing in 8,287 rheumatic disease patients. Arthritis Rheum 1991, 34(8):951-960.
18. Joushua F., Edmonds J., Lassere M. Power Doppler ultrasound in musculoskeletal disease; a systematic review. Semin Arthritis Rheum 2006, 36:99-108.
19. Naredo E., Rodriguez M., Campos C., Rodriguez-heredia J., Medina J., Giner E., et al. Validity, reproducibility, and responsiveness of a twelve joint simplified power Doppler ultrasonographic measurement of joint inflammation in rheumatoid arthritis. Arthritis Rheum 2008, 59(4):515-522.
20. Kawashiri S.Y., Kawakami A., Iwamoto N., Fujikawa K., Satoh K., Tamai M., et al. The power Doppler ultrasonography score from 24 synovial sites or 6 simplified synovial sites, including the metacarpophalangeal joints, reflects the clinical disease activity and level of serum biomarkers in patients with rheumatoid arthritis. Rheumatology (Oxford) 2011, 50(5):962-965.
21. Naredo E., Moller I., Cruz A., Carmona L., Garrido J. Power Doppler ultrasonographic monitoring of response to anti-tumor necrosis factor therapy in patients with rheumatoid arthritis. Arthritis Rheum 2008, 58(8):2248-2256.
22. Fries J.F., Spitz P., Kraines R.G., Holman H.R. Measurement of patient outcome in arthritis. Arthritis Rheum 1980, 23:137-145.
23. Ammer K., Melnizky P., Rathkolb O. HAQ (=Health Assessment Questionnaire) Scores of out-patients in a clinic for physical medicine. ÖZPMR, Österr Z Phys Med Rehabil 2002, 12(2):59-65.
24. El Meidany Y.M., El Gaafary M.M., Ahmed I. Cross-cultural adaptation and validation of an Arabic Health Assessment Questionnaire for use in rheumatoid arthritis patients. Joint Bone Spine 2003, 70(3):195-202.
25. Kurosaka D., Hirai K., Nishioka M., Miyamoto Y., Yoshida K., Noda K., et al. Clinical significance of serum levels of vascular endothelial growth factor, angiopoietin-1, and angiopoietin-2 in patients with rheumatoid arthritis. J Rheumatol 2010, 37(6):1121-1128.
26. Westra J., de Groot L., Plaxton S.L., Brouwer E., Posthumus M.D., Kallenberg C.G., et al. Angiopoietin-2 is highly correlated with inflammation and disease activity in recent-onset rheumatoid arthritis and could be predictive for cardiovascular disease. Rheumatology (Oxford) 2011, 50(4):665-673.
27. Okada T., Tsukano H., Endo M., Tabata M., Miyata K., Kadomatsu T., et al. Synoviocyte-derived angiopoietin-like Protein 2 contributes to synovial chronic inflammation in rheumatoid arthritis. Am J Pathol 2010, 176(5):2309-2319.
28. Kumpers P., David S., Haubitz M., Hellpap J., Horn R., Bröcker V., et al. The Tie2 receptor antagonist angiopoietin 2 facilitates vascular inflammation in systemic lupus erythematosus. Ann Rheum Dis 2009, 68:1638-1643.
29. da Silva J.A., Phillips S., Buttgereit F. Impact of impaired morning function on the lives and well-being of patients with rheumatoid arthritis. Scand J Rheumatol 2011, 125(Suppl.):6-11.
30. Tabata M., Kadomatsu T., Fukuhara S., Miyata K., Ito Y., Endo M., et al. Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab 2009, 10(3):178-188.
31. Naredo E., Collado P., Cruz A., Palop M.J., Cabero F., Richi P., et al. Longitudinal power Doppler ultrasonographic assessment of joint inflammatory activity in early rheumatoid arthritis: predictive value in disease activity and radiologic progression. Arthritis Rheum 2007, 57:116-124.
32. Firestein G.S. Evolving concepts of rheumatoid arthritis. Nature 2003, 423:356-361.
33. Brennan F.M., McInnes I.B. Evidence that cytokines play a role in rheumatoid arthritis. J Clin Invest 2008, 118:3537-3545.
34. Walther M., Harms H., Krenn V., Radke S., Faehndrich T.P., Gohlke F. Correlation of power Doppler sonography with vascularity of the synovial tissue of the knee joint in patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 2001, 44:331-338.
35. Gok M., Erdem H., Gogus F., Yilmaz S., Karadag O., Simsek I., et al. Relationship of ultrasonographic findings with synovial angiogenesis modulators in different forms of knee arthritides. Rheumatol Int (Germany) 2013, 33(4):879-885.
36. Terslev L., Torp-Pedersen S., Qvistgaard E., Kristoffersen H., Rogind H., Danneskiold-Samsoe B., et al. Effects of treatment with etanercept (Enbrel, TNRF:Fc) on rheumatoid arthritis evaluated by Doppler ultrasonography. Ann Rheum Dis 2003, 62(2):178-181.
37. Fiocco U., Ferro F., Vezzu M., Cozzi L., Checchetto C., Sfriso P., et al. Rheumatoid and psoriatic knee synovitis: clinical, gray-scale and power Doppler ultrasound assessment of the response to etanercept. Ann Rheum Dis 2005, 64(6):899-905.
38. Mandl P., Naredo E., Wakefield R.J., Conaghan P.G. D'AGOSTINO MA; OMERACT Ultrasound Task Force. A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter. J Rheumatol 2011, 38(9):2055-2062.
39. Dougados M., Jousse-Joulin S., Mistretta F., d'Agostino M.A., Backhaus M., Bentin J., et al. Evaluation of several ultrasonography scoring systems for synovitis and comparison to clinical examination: results from a prospective multicentre study of rheumatoid arthritis. Ann Rheum Dis 2010, 69(5):828-833.
40. Strunk J., Rumbaur C., Albrecht K., Neumann E., Müller-Ladner U. Linking systemic angiogenic factors (VEGF, angiogenin, TIMP-2) and Doppler ultrasound to anti-inflammatory treatment in rheumatoid arthritis [In Process Citation]. Joint Bone Spine (France) 2013, 80(3):270-273.
41. Foltz V., Gandjbakhch F., Etchepare F., Rosenberg C., Tanguy M.L., Rozenberg S., et al. Power Doppler ultrasound, but not low-field magnetic resonance imaging, predicts relapse and radiographic disease progression in rheumatoid arthritis patients with low levels of disease activity. Arthritis Rheum (United States) 2012, 64(1):67-76.
42. Chávez-López M.A., Hernández-Díaz C., Moya C., Pineda C., Ventura-Ríos L., Möller I., et al. Inter- and intra-observer agreement of high-resolution ultrasonography and power Doppler in assessment of joint inflammation and bone erosions in patients with rheumatoid arthritis. Rheumatol Int 2013, 33(1):173-177.